Our Department of Radiation Oncology is a national leader in translational research in radiation therapy.
The department is one of the top 10 radiation oncology departments in the country for amount of federal funding received for cutting-edge research. As of 2023, the Department of Radiation Oncology ranks in the top five nationally and internationally for National Cancer Institute (NCI)-sponsored national clinical trials cooperative group accruals.
This strong reputation in research has led University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) to be one of only four cancer centers in the country to have a Master Research Agreement with Varian Medical Systems, the market leader in the development of medical technology.
Our research department’s mission is to facilitate and provide services to:
- UM faculty researchers, assisting with study start-up and administration.
- Patients and the general public, providing up-to-date information about ongoing clinical studies in the University of Maryland’s Department of Radiation Oncology.
- Sponsors, helping them identify University of Maryland investigators for research participation.